title: Comparison of Cytotoxic Activity of Bile on HepG2 and CCRF-CEM Cell Lines: An in Vitro Study.
abstract: The aim of this study was to examine the effect of crude bile on the human HepG2 and CCRF-CEM cell lines. Cells were exposed to different dilutions of bile. Antiproliferative effects were determined by the cytotoxic MTT assay. Cells undergoing apoptosis were identified by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Bile administration resulted in dose-dependent cytotoxicity in both HepG2 and CCRF-CEM cell lines. Incubated cells exhibited morphologic features of apoptosis. Bile has significant cytotoxic activity in HepG2 and CCRF-CEM cancer cells via induction of apoptosis. The mechanism of apoptosis needs to be further evaluated. It may have clinical utility in the treatment of cancer after in vivo confirmation of activity.
authors: Organ Transplant Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
authors: Negar
authors: N
authors: Azarpira
authors: Fatemeh
authors: F
authors: Rastegar
authors: Maryam
authors: M
authors: Amiri
authors: Elaheh
authors: E
authors: Esfandiari
authors: Bita
authors: B
authors: Geramizadeh
keywords: Bile; Cytotoxicity; Neoplasms
references: World J Gastroenterol. 2008 Oct 7;14(37):5620-9
references: 18837077
references: Cancer Lett. 2005 Nov 8;229(1):49-57
references: 16157218
references: Expert Opin Pharmacother. 2010 Feb;11(3):387-92
references: 20102304
references: J Lipid Res. 2009 Oct;50(10):1955-66
references: 19346330
references: Curr Cancer Drug Targets. 2006 Dec;6(8):681-9
references: 17168673
references: Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G278-86
references: 21636532
references: J Physiol Pharmacol. 2010 Apr;61(2):185-92
references: 20436219
references: Cancer Lett. 2003 Sep 25;199(2):157-67
references: 12969788
references: Methods Mol Med. 2005;110:69-78
references: 15901928
references: Breast Cancer Res. 2008;10(6):R106
references: 19087284
references: Trends Mol Med. 2011 Oct;17(10):564-72
references: 21724466
references: Eur J Clin Invest. 2002 Jan;32(1):29-34
references: 11851724
references: Gynecol Oncol. 2007 Nov;107(2):344-9
references: 17720233
references: Gastroenterol Clin Biol. 2010 Aug-Sep;34(6-7):410-2
references: 20576377
references: Biochem Biophys Res Commun. 2010 Oct 1;400(4):649-54
references: 20807506
references: Nutr Cancer. 1998;31(2):111-8
references: 9770722